Yahoo Web Search

Search results

  1. 34 minutes ago · Swiss Pharma giant Roche (OTCQX:RHHBY) also has two candidates in early clinical studies. Outside bets include Zealand Pharma/Boehringer Ingelheim’s candidate survodutide and Altimmune’s ( ALT ...

  2. 18 hours ago · 2016年乳腺癌治疗最大的进步是癌症靶向的药物联合如何在11天内使11%的患者完全没有乳腺癌迹象。这项英国研究涉及257例HER2阳性乳腺癌,并联合两种药物分别来自GlaxoSmithKline(葛兰素史克公司)(NYSE:GSK) 和 Roche Holdings(罗氏制药) (NASDAQOTH:RHHBY)。

  1. People also search for